Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686

Show all 514 references

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

Items 301–400 of 806

Authors Insights on the Updated International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)
Miyamoto, S. D., Irving, C. A., Azeka, E., Adorisio, R., Blume, E. D., Bogle, C., Chubb, H., Conway, J. L., Cousino, M. K., Edelson, J. B., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.06.004 · Cited by 1
Extracellular Volume Fraction Analysis on Cardiac Computed Tomography Is Useful for Predicting the Prognosis of Hypertrophic Cardiomyopathy
Aoki, S., Takaoka, H., Kanaeda, T., Asada, K., Ota, J., Noguchi, Y., Matsumoto, M., Nishikawa, Y., Suzuki, K., Yashima, S., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12090372 · Cited by 1
Precision Negative Inotropy: The Rise of Cardiac Myosin Inhibitors in HCM
Skibicka, K., Skibicki, T., Wesołowska, W., & Bujak, R. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.84.65626 · Cited by 1
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy With Residual Obstruction After Alcohol Septal Ablation
Zhang, J., Hsi, D. H., Ta, S., Wang, J., Wang, B., Ma, H., Shan, B., Hu, R., Li, J., & Liu, L. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.08.355 · Cited by 1
Relación entre composición corporal y condición física de mujeres mayores hipertensas: un estudio exploratorio
Cerda, M. A. C., Fritz-Silva, N., Paredes, C. A., Hechenleiner, J. A., & Espinoza, A. M. (2025) · Retos · doi:10.47197/retos.v72.115010 · Cited by 1
Comparative efficacy of particulate embolic agents versus alcohol in percutaneous transluminal septal myocardial ablation
Li, Y., Li, Y., Zhu, L., Huang, B., Dong, Q., Luo, S., & YINTAO, C. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133952 · Cited by 1
Septal myectomy for obstructive hypertrophic cardiomyopathy: Comparison of outcomes of the transapical beating-heart and transaortic on-pump approaches
Qamar, Y., Li, R., Geske, J. B., Fang, J., Lahr, B. D., Lee, A. T., Ommen, S. R., Wan, S., Schaff, H. V., & Wei, X. (2025) · JTCVS Open · doi:10.1016/j.xjon.2025.09.041 · Cited by 1
Self-citation
Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy
Becher, P. M., Brunner, F. J., Weimann, J., Remmel, M., Schrage, B., Patten, M., Detter, C., Reichenspurner, H. C., Kirchhof, P. F., Blankenberg, S., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02773-7 · Cited by 1
Prognostic Implication of Right Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy
Hong, S. H., Park, E., Kwak, S., Kim, H., El-Naggar, H. M., & Lee, W. (2025) · Korean Journal of Radiology · doi:10.3348/kjr.2025.0301 · Cited by 1
Totally endoscopic transaortic septal myectomy with 3-dimensional visualization for hypertrophic obstructive cardiomyopathy: A case report
Định, N. H., Chuong, P. T. V., Thang, H. D., & Thuan, P. Q. (2025) · JTCVS Techniques · doi:10.1016/j.xjtc.2025.09.025 · Cited by 1
From Genetics to Phenotype: Understanding the Diverse Manifestations of Cardiovascular Genetic Diseases in Pediatric Populations
Gutmann, J. L., Spister, A., & Batičić, L. (2025) · Cardiogenetics · doi:10.3390/cardiogenetics15040029 · Cited by 1
Comparison of morrow procedure and transapical beating-heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis
Zhakayev, M., Tuleutayev, R., Нурбайкызы, Н. Ж., & Izmailovich, M. R. (2025) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1666236 · Cited by 1
Alcohol septal ablation in a patient with Fabry disease and multilevel left ventricular obstruction. A case report
Kashtanov, M. G., Vedernikov, A. A., Михайлович, М. Е., Raspopova, E. S., & Reitblat, O. M. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6295 · Cited by 1
Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany
Sedaghat‐Hamedani, F., Zema, C. L., Schultze, M., Garcia, T. B., Kossack, N., Borchert, J., Hernandez, E. J. M., Zhong, Y., Bluhmki, T., Krause, T., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02776-4 · Cited by 1
Manejo de la disfunción sistólica en pacientes con miocardiopatía hipertrófica: desafíos y perspectivas
Fernández, A., & Giordanino, E. F. (2025) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2025.10.002 · Cited by 1
Efficacy and Safety of Transapical Beating-Heart Myectomy in Patients Aged >65 Years With Hypertrophic Obstructive Cardiomyopathy
Ma, X., Cheng, C., Li, C., Hou, N., Feng, Y., Li, S., & Wei, X. (2025) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2025.10.014 · Cited by 1
Complete left bundle branch block resolution during treatment with Mavacamten: a case report of a first-in-class scenario
Marchionni, G., Alfarano, M., Ballatore, F., Costantino, J., & Chimenti, C. (2025) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaf592 · Cited by 1
Early Diastolic Release Flow Is a Sensitive Early Marker for Left Ventricular Apical Aneurysm in Patients with Hypertrophic Cardiomyopathy
Bukhari, S., Kassamali, A. A., Pronovost, H., Ehmsen, J. T., Wu, K. C., Madrazo, J., Hays, A. G., & Carrick, R. T. (2025) · CJC Open · doi:10.1016/j.cjco.2025.11.007 · Cited by 1
Associations between heart failure-related quality of life and clinical parameters in patients with hypertrophic cardiomyopathy: a cross-sectional analysis of data from a multicentre Japanese registry
Saotome, M., Akita, K., Kageyama, S., Suzuki, S., Ohno, K., Kamakura, M., Nawada, R., Takanaka, C., Wakabayashi, Y., Kanda, T., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101251 · Cited by 1
The impact of large v-waves of pulmonary artery wedge pressure in patients with wild-type transthyretin amyloid cardiomyopathy
Yamamoto, M., Izumiya, Y., Takashio, S., Morikawa, K., Oguni, T., Kuyama, N., Oike, F., Ishii, M., Usuku, H., Hanatani, S., et al. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.11.008 · Cited by 1
Exercise Rehabilitation for Heart Failure and Associated Cardiomyopathies
Stahl, M. E., Weeldreyer, N. R., MacNamara, J. P., Lozano, P. F. R., & Allen, J. D. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02313-9 · Cited by 1
Kardiovaskuläre Bildgebung mittels Kardio-CT und -MRT
Abanador-Kamper, N., Giannopoulos, A. A., Georgiadis, M., & Korosoglou, G. (2025) · Herz · doi:10.1007/s00059-025-05350-w · Cited by 1
Exercise Participation and Rehabilitation in Cardiomyopathies: An Updated Review
Russo, D., Gambardella, C., Volterrani, M., Lillo, R., Volpe, M., & Autore, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248683 · Cited by 1
Left ventricular deformation and tissue characteristics in hypertrophic cardiomyopathy patients with HFpEF: a CMR study
Liu, J., Zhao, Z., Cai, Q., Tian, J., Gao, J., Liu, H., Song, Y. H., Huang, Y., Li, Z., Huo, H., et al. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-02110-4 · Cited by 1
Clinical characteristics of 41 children with hypertrophic cardiomyopathy: A single-center retrospective study
Li, S.-G., Wei, C., Su, D., Cheng, C., Qin, S., Ye, B., & Pang, Y. (2025) · Journal of International Medical Research · doi:10.1177/03000605251399040 · Cited by 1
Anaesthesia and perioperative transoesophageal echocardiography in obstructive hypertrophic cardiomyopathy
Palamattam, D. J., Panidapu, N., Srimurugan, B., Poduval, D., Joseph, T. J., Jose, J., Madathil, T., Jacob, D. P., Varma, P. K., & Neema, P. K. (2025) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-025-02083-7 · Cited by 1
Evaluating the role of mavacamten in symptomatic non-obstructive hypertrophic cardiomyopathy: the ODYSSEY-HCM trial
Hosseini, K., Kazemian, S., Harikrishnan, S., Sverdlov, A. L., Cheema, B. S., Juma, Z. H. A., Biering‐Sørensen, T., & Grupper, A. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10578-z · Cited by 1
Systolic and diastolic blood pressure, abdominal obesity, and alcohol consumption contribute to the risk of hypertrophic and dilated cardiomyopathies in European and East Asian populations
Zhang, W., Qiu, L., Cao, Z., Xie, J., Jin, J., Bai, R., Xiang, J., Zou, Y., Peng, X., Wan, R., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04524-x · Cited by 1
Distinct Subgroups and Outcomes in Patients With Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy
Zhang, S., Yuan, Q., Zhu, Z., Deng, L., Nie, H., Liang, T., & Wang, X. (2025) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2025.12.009 · Cited by 1
Relationship between symptom assessment and cardiopulmonary exercise testing in patients with obstructive hypertrophic cardiomyopathy
Bjerregaard, L., Maron, M. S., Jensen, M., Dybro, A. M., Rasmussen, T. R., Poulsen, S. H., & Rowin, E. J. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.134147 · Cited by 1
Hemodynamic and symptomatic response in hypertrophic obstructive cardiomyopathy patients on myosin inhibitor therapy
Seuthe, K., Feidakis, A., Nies, R. J., Brüwer, M., Pennig, L., Kaya, K., ten Freyhaus, H., Baldus, S., & Pfister, R. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1639855 · Cited by 1
Social Determinants of Health and Clinical Outcomes in Hypertrophic Cardiomyopathy
Hafeez, N., Claggett, B. L., OWENS, A. T., Helms, A. S., Saberi, S., Lampert, R., Stendahl, J. C., Ashley, E. A., Parikh, V. N., Lakdawala, N. K., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2025.4869 · Cited by 1
Self-citation
Panorama da Atuação Profissional em Tomografia e Ressonância Magnética Cardiovascular no Brasil
Costa, I. B. S. D. S., Torreão, J. A., Fernandes, J. D. L., Trad, H. S., Liberato, G., Neto, R. S., Barberato, S. H., Pinto, I. M. F., & Senra, T. (2025) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.36660/abcimg.20250053 · Cited by 1
Beta-Blocker therapy improves survival after concomitant septal myectomy and aortic valve replacement
So, P., Patel, M., Iyengar, A., Weingarten, N., Dominic, J., Belec, A., Ho, J., & Atluri, P. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03588-3 · Cited by 1
Focused Transthoracic Echocardiogram Surveillance Protocol for Hypertrophic Cardiomyopathy Patients on Mavacamten Therapy
Pearlman, A., Hellyer, R. L., Burns, C., MEDI, C., & Gray, B. R. (2026) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.026 · Cited by 1
Genetic diversity and molecular mechanisms in hypertrophic cardiomyopathy: toward personalized therapy
Marwaha, K., Mody, B. P., Holland, N. A., Lane, M., Shoemake, B. D., Singh, N., & Mody, F. V. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2025 · Cited by 1
Effect of mavacamten on left ventricular diastolic function and left atrial remodelling in obstructive hypertrophic cardiomyopathy
Cohen, N., Lucas, C. H., Idini, C., Conte, E., Philip, M., Stolpe, G., Martel, H., Quaranta, S., & Habib, G. (2026) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2026.01.006 · Cited by 1
Gene-based Therapies for Genetic Cardiomyopathies: Molecular Medicine for Heart Disease
Sharma, S., Sadasivan, C., Yan, Y., & Oudit, G. Y. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.01.055 · Cited by 1
Prognostic Implications of Mitral Regurgitation Across Hypertrophic Cardiomyopathy Subtypes: A Report From REVEAL-HCM Study
Obayashi, Y., Kato, T., Shiomi, H., Nakatsuka, K., Kitaoka, H., Sakata, Y., Dohi, K., Tokita, Y., Matsushima, S., Amano, M., et al. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013977 · Cited by 1
Associations between specific non-sustained ventricular tachycardia characteristics and sudden cardiac death in hypertrophic cardiomyopathy
Zhang, Y., Qin, F., Guan, Y. F., Wang, J., Pu, L., Xia, Y., Zhang, C., Wang, D., Wu, X., Zhang, M., et al. (2025) · EP Europace · doi:10.1093/eurheartj/ehaf784.2588 · Cited by 1
Cardiac disease in systemic sclerosis: Integrating pathobiology with clinical management
Sutanto, H., Rachma, B., & Yuliasih (2026) · Rheumatology & autoimmunity · doi:10.1002/rai2.70040 · Cited by 1
“We Don’t Really Know Each Other”: A Mixed Methods Study Exploring Patient-Clinician Values-Centered Discussions Following Ventricular Assist Device Implantation
Bechthold, A. C., Wells, R. D., McIlvennan, C. K., Saylor, M. A., Matlock, D. D., LeJeune, J., & Dionne-Odom, J. N. (2026) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001305 · Cited by 1
Long-Term Efficacy of Mavacamten in Reducing Left Ventricular Mass in a Multi-Ethnic Cohort With Obstructive Hypertrophic Cardiomyopathy
Morgan, W., Barron, K., Hudson, O., Smith, C., Patel, N., Arora, P. K., & Arora, G. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.02.015 · Cited by 1
Genetics in Hypertrophic Cardiomyopathy: An Evolving Clinical Landscape
Brögger, M. N., Reyes, I. J. C., García-Hernández, S., & Ochoa, J. P. (2026) · Cardiac failure review · doi:10.15420/cfr.2025.12 · Cited by 1
Multimodality imaging of a rare case of apical hypertrophic cardiomyopathy with endomyocardial fibrosis and myocardial calcification: case report and literature review
Yi, Y., Wang, S., & Peng, D. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1774080 · Cited by 1
Transient Ventricular Capture Loss Following Alcohol Septal Ablation in Left Bundle Branch Area Pacing: A Case Report
Liu, C. H., Yao, J., Chen, C., Chen, K., & Wu, H. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70298 · Cited by 1
Multidisciplinary management of patients with hypertrophic cardiomyopathy
Rudenko, K. V., Danchenko, P. A., Rzhanyi, M., Chyzhevska, O. O., Bei, A. O., & Kovalyova, O. M. (2026) · Ukrainian Journal of Cardiology · doi:10.31928/2664-4479-2026.1.7585 · Cited by 1
Predictive Value of Existing Prediction Models for Short-Term Outcomes after Percutaneous Intramyocardial Septal Radiofrequency Ablation
Yin, J., Ta, S., Wang, J., Hsi, D. H., Shan, B., Li, J., Li, W., Hu, R., Wang, B., Kang, N., et al. (2026) · Cardiology · doi:10.1159/000551275 · Cited by 1
Outcomes and Sex Differences in Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy–Insights from a Japanese Nationwide Registry
Yamaguchi, T., Takahara, M., Kohsaka, S., Ishii, H., Takamisawa, I., Kodama, T., Shinke, T., Amano, T., & Kozuma, K. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.03.002 · Cited by 1
Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy
Lopes, L. R. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag059 · Cited by 1
Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy
Satomi, S., Suzuki, R. H., Yuchi, Y., Kanno, H., Inoue, M., Teshima, T., & Matsumoto, H. (2026) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x261433060 · Cited by 1
The Novel ACTC1 p. Gly50Ser Variant Is Associated With Arrhythmia and Secondary Features of HCM Without Hypertrophy
Gossios, T. D., Ntelios, D., Zegkos, T., Parcharidou, D. G., Rouskas, P., Katranas, S. A., Papoulidis, I., Ninios, V. N., Ziakas, A., & Efthimiadis, G. K. (2026) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.70120 · Cited by 1
Safety and efficacy of physical activity in hypertrophic cardiomyopathy patients: a systematic review and metanalysis
Borrelli, F., Tarditi, F., Andreis, A., Mabritto, B. M. T., Benso, A. S., & Toso, E. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1739956 · Cited by 1
Suicide left ventricle after aortic valve intervention: Mechanisms, risk phenotypes, and clinical considerations
Tang, D. C. Y., Salter, R., Chatfield, A., Young, P. J., & Ch’ng, S. L. T. (2026) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2026.03.005 · Cited by 1
T‐Wave Oversensing in Patients With Left Bundle Branch Pacing: A Report of Three Cases and Review of Literature
Chen, F., Wu, Y., Xu, D., Zeng, J., Wang, Y., Qian, Z., Zou, J., & Hou, X. (2026) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70197 · Cited by 1
Revisiting the Genetics of Hypertrophic Cardiomyopathy: From Sarcomeres to Polygenic Modulation and Clinical Translation
Carella, M. C., Dicorato, M. M., Basile, P., Dentamaro, I., Santoro, D., Carulli, E., Latorre, M. D., Urgesi, E., Monitillo, F., Resta, N., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062327 · Cited by 1
Caracterização Genética e Clínica de uma Coorte de Pacientes com Cardiomiopatia Hipertrófica no Sul do Brasil
Beuren, T. M. A., Scolari, F. L., Sperb‐Ludwig, F., Ferrari, F., Rossi, A. P., Zawislak, R. B., van Tintelen, J. P., & Stein, R. J. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250420 · Cited by 1
Advances in Non-Invasive Myocardial Stiffness Assessment and Clinical Applications in Hypertrophic Cardiomyopathy
Gao, Y., Qi, N., Gao, H., Deng, Y., & Liu, Y. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm47459 · Cited by 1
Prognostic value of cardiac fibroblast activation heterogeneity assessed by FAPI PET radiomics in hypertrophic cardiomyopathy: a proof-of-concept study
Song, H., Ding, J., Zhao, J., Wang, Y. N., Wu, Q., Yang, M., & Wang, L. (2026) · Open Heart · doi:10.1136/openhrt-2025-003537 · Cited by 1
Machine learning–based risk stratification identifies heart failure with preserved ejection fraction as an independent predictor of adverse outcomes in hypertrophic cardiomyopathy
Zhang, W., Zhao, H., Tian, Z.-C., Fu, W., Li, Z., Geng, Z., He, Y., He, H., Wu, P., Zhu, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-46573-z · Cited by 1
New and recurrent atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy receiving mavacamten
Bukhari, S., Gasperetti, A., Rivers, B. J., Wu, K. C., Barth, A. S., Madrazo, J., & Carrick, R. T. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.04.033 · Cited by 1
Update: Cardiac Myosin Inhibitors in Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
Ramchand, J., & Bennett, J. S. (2026) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-026-01142-5 · Cited by 1
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report
Lucas, S., Hennart, B., de Groote, P., Lamblin, N., Ridon, H., Dupré, C., Lionet, A., & Lemesle, G. (2026) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytag368 · Cited by 1
Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten
Bavishi, A. A., Marella, D., Kim, J. H., & Martinez, M. W. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108253 · Cited by 1
Self-citation
Efficacy and safety of exercise for hypertrophic cardiomyopathy: a systematic review and meta-analysis
Amin, A. M., Shehada, W., Elgebaly, M., Ayman, D., Ibrahim, M., Abdelazeem, B., & Felpel, K. D. (2026) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2026.2667666 · Cited by 1
Population-Based Analysis of Rare Genetic Variants in Sudden Cardiac Arrest
Kransdorf, E. P., Mathias, M., Nakamura, K., Chugh, H. S., Nguyen, D., Tyrer, J. P., Pharoah, P. D., Reinier, K., Coban‐Akdemir, Z., Boerwinkle, E., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.03.016 · Cited by 1
Registro de miocardiopatía hipertrófica en centros no especializados: resultados finales
Cáceres, L., Antoniolli, M., Kanchi, M., Mazo, G., Streitenberger, G., Gomez, L. E., Cohendoz, S., Sadouet, C. C., Cano, R., Costa, Y. C., et al. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v94.i2.20990 · Cited by 1
The present and the future of risk stratification for and prevention of sudden cardiac death: A Heart Rhythm Society think tank meeting
Al‐Khatib, S. M., Ackerman, M. J., Califf, R. M., Chung, M. K., Chugh, S. S., Curtis, A. B., Dagres, N., Ellenbogen, K. A., Felker, G. M., Goldenberg, I., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.05.040 · Cited by 1
From Molecules to Machines: An Integrative Framework Linking Molecular Pathogenesis, Multi‐Factorial Risk, Risk Stratification, Clinical Management, and Artificial Intelligence in QT Prolongation and Sudden Cardiac Death
Farjam, M., Yazdanpanah, M. H., & Fereydouni, N. (2026) · Clinical Cardiology · doi:10.1002/clc.70370 · Cited by 1
Apical Hypertrophic Cardiomyopathy Misdiagnosed as Hypertensive Heart Disease Due to Anchoring Bias in an African Man: A Case Report
Okema, J. N., Chukwuocha, C. U., Danvictor, E., Uche, C. N., Ekengwu, C., Egharevba, J. E., Ebunoluwa, E., & Bongomin, F. (2026) · International Medical Case Reports Journal · doi:10.2147/imcrj.s605653 · Cited by 1
From checklists to phenotypes: a new era in individualized hcm risk stratification with CMR
Schulz, A., Abanador-Kamper, N., & Korosoglou, G. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03754-1 · Cited by 1
Present and Future Options for Pharmacotherapy in Cardiovascular Disease: Hemodynamic and Mechanistic Therapeutic Targets
Cabré, F., & Cascante, M. (2026) · Medical Sciences · doi:10.3390/medsci14020331 · Cited by 1
Echocardiographic drag effect index and its association with response to mavacamten in obstructive hypertrophic cardiomyopathy
Ha, H.-S., Yoon, S. G., Cho, S. H., Lee, H. J., Kim, I.-C., Kim, H., Son, J., Nam, J., Choi, K., Lee, H., et al. (2026) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeag156 · Cited by 1
Sex Differences in Characteristics and Outcomes Among Patients With Hypertrophic Cardiomyopathy: Insights From the REVEAL‐HCM Study
Nakamura, M., Abe, H., Ueda, Y., Kitaoka, H., Sakata, Y., Dohi, K., Tokita, Y., Kato, T., Matsushima, S., Amano, M., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.046708 · Cited by 1
Enhanced risk stratification in hypertrophic cardiomyopathy through the integration of extracellular volume fraction on cardiovascular magnetic resonance
Lee, H., Gwak, S., Lee, S., Kim, K., Cho, I. K. S. U. N. G., Shim, C. Y., Choi, B. W., Ha, J., Kim, Y. J., & Hong, G. (2026) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeag146 · Cited by 1
Cardiomyopathy in glycogen storage diseases: diagnosis, prognosis, and advanced management
Patel, U., Gunes, E., Chawla, A., Ashman, K., Taub, A., Arakelyan, T., Madani, A., Patel, K., Bui, Q., & Adler, E. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10648-w · Cited by 1
Risk models for sudden cardiac death in cardiomyopathies: clinical, methodological and ethical challenges
Antonopoulos, A. S., Gardikioti, V., Gossios, T. D., Panagiotakos, D. B., Tsioufis, K. P., & Vlachopoulos, C. V. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag161 · Cited by 1
Imaging-Based Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy: Current Evidence and Clinical Perspectives
Pardo, È. R., Sóñora-López, S., Casas, G., Ceballos, M. S., Videla, L. S., Freire, J. L., Teixidó‐Turà, G., González, I. F., & Rodríguez-Palomares, J. F. (2026) · Medical Sciences · doi:10.3390/medsci14030390 · Cited by 1
Exercise Training in Hypertrophic Cardiomyopathy: A Systematic Review, Meta-analysis, and Meta-regression
Bayonas‐Ruiz, A., Gimeno, J. R., Muñoz‐Franco, F. M., Molina, M. S., & Bonacasa, B. (2026) · Sports Medicine - Open · doi:10.1186/s40798-026-01059-0 · Cited by 1
Machine learning algorithms for predicting arrhythmic events in Hypertrophic Cardiomyopathy: limited enhancement beyond late gadolinium enhancement
Pereira, J. C., Amador, R., Vieira, A., Carvalho, R. A., Castilho, B., Arteaga, E., Rochitte, C. E., Rocha, B. R., Lopes, P. M., Abecasis, J., et al. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03779-6 · Cited by 1
Evaluation of the effect of mavacamten on left ventricular function in obstructive hypertrophic cardiomyopathy using myocardial work
Wan, L., Chen, X., Huang, Z., Ren, J., Lu, W., & Ran, H. (2026) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.70084 · Cited by 1
Long-term impact of aficamten on patient-reported outcome measures in obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
Weiner, S. D., Liang, L. W., Masri, A., Abraham, T. P., Villa, R. B., Cooper, R. M., Elliot, P. M., de Feria, A., Maron, M. S., Oręziak, A., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag244 · Cited by 1
Self-citation
Beyond Doppler: Scalable AI Detection of LVOT Obstruction in HCM
Crystal, O. R., Farina, J., Scalia, I. G., Ayoub, C., Etchegoyen, C. V., Chollet, L., Park, H., Kim, K. A., Arsanjani, R., Lester, S. J., et al. (2026) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.126.019956 · Cited by 1
Left Atrial Reservoir Strain Improves Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy
Kwak, S., Kang, Y., Kim, J., Jeong, M.-H., Lee, H.-J., Park, J., Lee, S., Kim, Y.-J., Kim, H., & Lee, S.-C. (2026) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2026.08.007 · Cited by 1
Self-citation
International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, B. J., Siontis, K. C., Tower-Rader, A. F., Massera, D., Koethe, B. C., Bilen, O., Phelan, D., Arnold, A. D., Mohal, J. S., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078597 · Cited by 1
Self-citation
Dual-flow convolutional neural network for automatic measurement of left ventricular ejection fraction and global longitudinal strain in echocardiography
Zhang, Z., Zhu, Y., Chen, S., Dong, Y., Zhang, Y., Wu, C., Zhang, Z., Zhu, S., Liu, M., Sun, Z., et al. (2026) · PLOS Digital Health · doi:10.1371/journal.pdig.0001128 · Cited by 1
Effect of Aficamten on Cardiac Structure and Function in Patients With Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Hegde, S. M., Wang, X., Bhatia, A., Peña‐Peña, M. L., Sherrid, M. V., Figueiredo, E. L., Arad, M., Villa, R. B., Choudhury, L., Claggett, B. L., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.082343 · Cited by 1
Self-citation
Beyond the 15-mm Threshold
Abdelfattah, O., Nagueh, S. F., & Martinez, M. W. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.07.042 · Cited by 1
Self-citation
Mechanistic diversity within RLC-dependent myosin ATPase inhibitors differentiates EDG-7500, a diastolic-selective cardiac sarcomere modulator
Emter, C. A., Henze, M., Duvall, M., Lehman, S., Lee, L., Barthel, B. L., Hawryluk, N. A., Madden, M. C., Wu, Y., Perry, A., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.203086 · Cited by 1
Prognostic significance of cardiac magnetic resonance parameters in hypertrophic cardiomyopathy: a multicentre study
Ho, S. Y., Yiu, K., Leung, K. H., Sin, T. H., Lee, T. Y., Lam, K. H., Fong, L. C. W., Cheng, K. Y., Mak, Y. H., Wong, C. K., et al. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03827-1 · Cited by 1
Imaging Advances in Heart Failure
Thamman, R., Hosseini, N., Dikou, M.-L., Hassan, I. U., Marchenko, O. Y., Abiola, O., & Grapsa, J. (2024) · Cardiac failure review · doi:10.15420/cfr.2023.10 · Cited by 1
Definitional Challenges in Understanding Hypertrophic Cardiomyopathy
Federspiel, J. M., Pfeifer, J., Ramsthaler, F., Reil, J., Schmidt, P. H., & Sequeira, V. (2024) · Diagnostics · doi:10.3390/diagnostics14222534 · Cited by 1
Treatment options for hypertrophic obstructive cardiomyopathy: a patient-centric review
Cirillo, C., Perillo, A., Monda, E., Palmiero, G., Verrillo, F., Rubino, M., Diana, G., Dongiglio, F., Caiazza, M., Cirillo, A., et al. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2436659 · Cited by 1
Cardiologia Teoria e Prática - Edição XVIII
Freitas, G. B. L. D., CAMPOS, M. D., CIPOLA, B. V., & Barbosa, A. L. (2024) · doi:10.59290/978-65-6029-190-4 · Cited by 1
Global burden of heart failure in children and adolescents from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019
Lai, Z.-H., Liu, Z., Xie, J., Xu, W., Jiang, X., Yang, Y., He, C., Shi, Y., Fan, X., & Li, X. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-024-00868-1 · Cited by 1
Case Report: Dual-chamber pacemaker for hypertrophic cardiomyopathy with bradyarrhythmia and idiopathic pericardial effusion: a report of two cases and literature review
Liu, C., Zheng, F., Gao, Y., Wang, Z., Zhang, X., & Tian, X. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1518000 · Cited by 1
Potential impact of long-term ambulatory electrocardiographic monitoring on estimated sudden cardiac death risk in childhood hypertrophic cardiomyopathy
Norrish, G., Field, E., Cervi, E., & Kaski, J. P. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.1950 · Cited by 1
Predictive model development for left atrial remodeling in hypertrophic cardiomyopathy
Zhang, B., Zhao, C., Wang, F., Yang, C., Huo, X., Cai, H., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-97144-7 · Cited by 1
Is It Wise to Forget Exercise Stress Echocardiography in the Study of Chest Pain in Children? Comment on Huang, S.-W.; Liu, Y.-K. Pediatric Chest Pain: A Review of Diagnostic Tools in the Pediatric Emergency Department. Diagnostics 2024, 14, 526
Cotrim, N., & Cotrim, C. (2025) · Diagnostics · doi:10.3390/diagnostics15091106 · Cited by 1
Explorando o MYH7 nas Cardiomiopatias: Fatores Genéticos e Desfechos Clínicos
Pires, L. V. L., Correia, V. M., Lipari, L. F. V. P., Andrade, F. A., Fernandes, F., Madrini, V., de Carvalho, M. L. P., Napolitano, G., da Silva, E. A., Vilalva, K. H., et al. (2025) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20240054 · Cited by 1

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks